The comparative time of drug addition study using standard anti-HIV agents demonstrated that PD 404182 1 showed a similar antiviral profile against HIV-1 IIIB infection with that of DS 5000 (adsorption inhibitor) and enfuvirtide (fusion inhibitor). This suggests that compound 1 apparently impairs virus replication at the early stage of HIV infection. Additionally, the antiviral activities of 1 against multiple HIV clades suggest that the target molecule of 1 is not chemokine receptors (CC chemokine receptor type 5 or CXC chemokine receptor type 4). However, the mode of action and mechanism of antiviral activity of 1 were not fully elucidated.
Photoaffinity labeling is an efficient approach to identify the target protein(s) of biologically active molecules [1] [2] [3] [4] . In modern drug discovery, there have been a number of successful examples that have determined the target molecules and identified the binding site through the formation of a covalent bond between the ligand and the specific protein [5] [6] [7] . In general, photoaffinity probes contain three functional groups: a bioactive scaffold, a photoreactive group and an indicator group. A biotin-tag is widely employed as an indicator because biotinylated proteins can be detected and isolated by several immunological methods or through a biotin-avidin interaction [8] [9] [10] [11] . A terminal alkyne is an alternative indicator for Huisgen cycloaddition-mediated conjugation with various azide-modified reporters, such as fluorescent-azide and biotin-azide after the crosslinking reaction onto the target protein(s). (For examples of alkyne-conjugated photoaffinity probes with benzophenone, see [12] [13] [14] [15] [16] ).
Trifunctional probes for the target protein(s) of 1 and the derivatives were designed on the basis of the SAR investigations. In the SAR study, the introduction of a hydrophobic group on the benzene ring and the cyclic amidine substructures effectively improved antiviral activity (compounds 2-4, Fig. 4 .1). The author expected that these moieties would potentially take part in a favorable interaction(s) with the target molecule(s), and the incorporation of a hydrophobic and photoreactive benzophenone group on the pyrimidobenzothiazine scaffold would be tolerated. Additionally, the N-alkoxycarbonyl piperidine group onto the amidine substructure of 1 reproduced potent anti-HIV activity (compound 5), indicating that this part could be used as a linkage position for the addition of functional groups.
With this in mind, the author designed three photoaffinity probes. Compound 6 is modified with indicator biotin via a photoreactive benzophenone group onto the benzene ring substructure (Fig. 4.2 ). Compound 7 equips the biotin and benzophenone groups on the right-part amidine moiety. The biotin moiety is conjugated with benzophenone via a polyethylene glycol (PEG) linker as the spacer. Compound 8 is an alkyne-containing derivative.
Synthesis of the probe 6 started with the preparation of benzophenone boronic acid pinacol ester 11 (Scheme 4.1). Condensation of p-(hydroxymethyl)benzoic acid 9 and N,O-dimethyl-hydroxylamine followed by TBDPS protection of a primary hydroxyl group gave an amide 10. Subsequent nucleophilic addition of an in situ-generated organolithium compound easily provided the desired boronate 11 [17] . Alkylation of compound 2a with p-methoxybenzyl (PMB) bromide followed by Suzuki-Miyaura cross coupling with compound 11 afforded a benzophenoneconjugated pyrimidobenzothiazine 13. Desilylation of 13 and the subsequent reaction with p-nitrophenyl chloroformate afforded the carbonate 16. The biotin moiety was incorporated by reaction of 16 with biotin-PEG-NH 2 (15) which was prepared by catalytic hydrogenation of azide 14 [18] . TFA-mediated deprotection of the PMB group in compound 17 provided the desired probe 6. Synthesis of the biotin-conjugated probe 7 is outlined in Scheme 4.2. PMB protection of compound 18 followed by the selective removal of the PMB group on the piperidine ring provided compound 20. Separately, the synthesis of biotinbenzophenone adduct 23 started from 4-(tert-butyldiphenylsilyloxy)methyl-4 0 -(hydroxymethyl)benzophenone 21 [19] . The treatment of 21 with chloroformate furnished a carbonate 22. Biotin-PEG-NH 2 15 was successfully conjugated onto 22 to give the biotin-benzophenone adduct 23. Desilylation of 23, treatment with pnitrophenyl chloroformate and coupling with 20 provided a biotin/benzophenoneconjugated 26. PMB deprotection of 26 afforded the desired probe 7. The author next investigated the synthesis of alkyne-containing probe 8 (Scheme 4.3). Suzuki-Miyaura cross coupling of compound 27 with boronate 11 gave compound 28. Subsequent modifications including desilylation, propargylation, and removal of the tert-butyl group provided the expected alkyne-conjugated probe 8.
The antiviral activities of probes 6-8 against HIV-1 IIIB were measured by multinuclear activation of a galactosidase indicator (MAGI) assay. Both biotinconjugated probes 6 and 7 showed potent anti-HIV activity with EC 50 values of 6.87 and 5.11 lM, respectively (Table 4.1). These activities were slightly lower than that of compound 1; however, the incorporation of large functional groups including benzophenone, the PEG linker and the biotinyl reporter was largely tolerated. Alkyne-conjugated probe 8 potently inhibited HIV infection (EC 50 = 0.64 lM). These probes 6-8 represent promising tools for the identification of the target molecule(s) of compound 1 and the derivatives.
Probes 6 and 7 were applied to the experiment for target identification of compound 1 and the derivatives. After HIV-1-infected H9 cells (H9IIIB) were incubated with a probe (6 in the presence or absence of 3a, or 7) for 1 h, the cells were exposed to UV-Vis light ([300 nm) for 1 min. After cell lysis, the biotinylated proteins were captured with NeutrAvidin agarose beads. The whole was subjected to separation by SDS-PAGE followed by Western blot analysis. Eight bands of 95, 80, 75, 70, 60, 55, 48 and 40 kDa proteins were observed from the cell samples incubated with probe 6 (Lane A, Fig. 4.3) . These bands were competed by unlabeled compound 3a, suggesting that the labeling was PD 404182-specific (Lane C). In contrast, these bands, with the exception of the 70 and 40 kDa bands, were not detected in the cells incubated with probe 7 (Lane B). This observation indicated that the potential target proteins did not fully interact with the benzophenone group on the right-part amidine moiety in the pyrimidobenzothiazine scaffold of 7. This experiment demonstrated that the synthesized probe 6 could be useful for the identification of the target protein(s) of compound 1. In conclusion, the author designed and synthesized novel photoaffinity probes of PD 404182 with photoreactive benzophenone, and biotin or alkyne indicators. The probes exhibited equipotent or slightly less potent anti-HIV activities when compared with the activity of the parent compound 1. Photoaffinity labeling experiments suggest that these probes could be useful in the identification of a potential target protein(s), the binding site on the target protein(s) and the mechanism(s) of action of PD 404182 derivatives.
Experimental Section

General Methods
All moisture-sensitive reactions were performed using syringe-septum cap techniques under an Ar atmosphere and all glasswares were dried in an oven at 80°C for 2 h prior to use. Melting points were measured by a hot stage melting point apparatus (uncorrected). For flash chromatography, Wakogel C-300E (Wako) or aluminum oxide 90 standardized (Merck) was employed. For preparative TLC, TLC silica gel 60 F254 (Merck) or TLC aluminum oxide 60 F254 basic (Merck) were employed. For analytical HPLC, a COSMOSIL 5C18-ARII column (4.6 9 250 mm, Nacalai Tesque, Inc., Kyoto, Japan) was employed with a linear gradient of CH 3 CN containing 0.1 % (v/v) NH 3 at a flow rate of 1 mL/min on a The cells were exposed to UV light for 1 min and were lysed. The resulting photolabeled proteins were captured onto NeutrAvidin-agarose and the whole was subjected to SDS-PAGE. The resulting gel was analyzed by Western blotting with streptavidin-HRP Shimadzu LC-10ADvp (Shimadzu Corp., Ltd., Kyoto, Japan), and eluting products were detected by UV at 254 nm.
1 H-NMR spectra were recorded using a JEOL AL-400 or a JEOL ECA-500 spectrometer, and chemical shifts are reported in d (ppm) relative to Me 4 Si (CDCl 3 ) or DMSO (DMSO-d 6 ) as internal standards. 13 C-NMR spectra were recorded using a JEOL AL-400 or JEOL ECA-500 spectrometer and referenced to the residual solvent signal. 19 F-NMR spectra were recorded using a JEOL ECA-500 and referenced to the internal CFCl 3 (d F 0.00 ppm).
1 H-NMR spectra are tabulated as follows: chemical shift, multiplicity (b = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant(s), and number of protons. Exact mass (HRMS) spectra were recorded on a JMS-HX/HX 110 A mass spectrometer. Infrared (IR) spectra were obtained on a JASCO FT/IR-4100 FT-IR spectrometer with JASCO ATR PRO410-S. The purity of the probes 6-8 was determined by HPLC analysis as [95 %. Synthesis and characterization data of compounds 2a, 18, and 27 are shown in Chap. 3.
4-[(tert-Butyldiphenylsilyloxy)methyl]-N-methoxy-N-methylbenzamide (10)
To a mixture of 4-(hydroxyl-methyl)benzoic acid 9 (4.6 g, 30.0 mmol), N,Odimethylhydroxylamine hydrochloride (14.6 g, 150.0 mmol), Et 3 N (21.7 mL, 150.0 mmol) in DMF (300 mL) were added EDCÁHCl (11.5 g, 60.0 mmol) and HOBtÁH 2 O (9.2 g, 60.0 mmol). After being stirred at rt overnight, solvent was evaporated. The residue was dissolved in EtOAc, and washed with 1 N HCl, sat. NaHCO 3 , brine, and dried over MgSO 4 . The filtrate was concentrated to give crude Weinreb amide (4.05 g, ca. 20.7 mmol). To the mixture of the Weinreb amide, a solution of Et 3 N (8.98 mL, 62.1 mmol) and DMAP (252.9 mg, 2.1 mmol) in CH 2 Cl 2 (138 mL) was slowly added TBDPSCl (5.83 mL, 22.8 mmol). After being stirred at rt for 3 h, the reaction mixture was quenched with water. After concentration, the residue was dissolved in EtOAc. The mixture was washed with sat. NaHCO 3 , brine, and dried over MgSO 4 . After concentration, the residue was purified by flash column chromatography over silica gel with n-hexane-EtOAc (3:1) to give the title compound 10 as colorless oil (6.98 g, 49 %): IR (neat) cm 
4-[(tert-Butyldiphenylsilyloxy)methyl]-4
0 -(4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzophenone (11) To a solution of 1,4-dibromobenzene (3.13 g, 13.3 mmol) and 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.80 mL, 13.8 mmol) in anhydrous THF (60 mL) was added t-BuLi (19.4 mL, 1.55 M in pentane, 30.0 mmol) dropwise over 3 min at -78°C under an Ar atmosphere. After being stirred at -78°C for 30 min, additional t-BuLi (19.4 mL, 1.55 M in pentane, 30.0 mmol) was added dropwise over 3 min. After being stirred at the same temperature for additional 20 min, compound 10 (3.25 g, 7.5 mmol) was added. The reaction mixture was warmed to rt over 1 h and quenched with sat. NH 4 Cl. The whole was extracted with EtOAc and the extract was dried over MgSO 4 . After concentration, the residue was purified by silica gel chromatography with n-hexane-EtOAc (9:1) to give the title compound 11 as yellow oil (3.60 g, 83 %): IR (neat) cm After being stirred at rt for 1 h, the reaction mixture was quenched with H 2 O. The whole was extracted with EtOAc, and washed with sat. NaHCO 3 , brine, and dried over MgSO 4 . After concentration, the residue was purified by flash column chromatography over aluminum oxide with n-hexane-EtOAc 
N-(2-[2-{2-(2-Aminoethoxy)ethoxy}ethoxy]ethyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno [3,4-d]imidazol-4-yl]pentanamide (15)
10 % Pd/C (wetted with ca. 55 % water, 160.0 mg) was added to the solution of biotin-amine 14 6 (116.0 mg, 0.26 mmol) in MeOH (2.0 mL). After being stirred at rt overnight under a H 2 atmosphere, the mixture was filtered through a Celite pad and concentrated. The crude product was used for the next step without further purification. (6) TFA (2.0 mL) was added to a mixture of 17 (62.9 mg, 0.063 mmol) in small amount of CHCl 3 (1 or 2 drops) and MS4Å (300 mg, powder, activated by heating with Bunsen burner). After being stirred at rt for 4 h, Et 3 N was added dropwise to the stirring mixture at 0°C to adjust pH to 8-9. The whole was extracted with CHCl 3 , and washed with sat. NaHCO 3 , brine, and dried over MgSO 4 . After concentration, the residue was purified by flash chromatography over aluminum oxide with To a solution of 19 (60.6 mg, 0.10 mmol) in CH 2 Cl 2 (0.5 mL) were added Et 3 N (28.9 lL, 0.20 mmol) and 1-chloroethyl chloroformate (21.8 lL, 0.20 mmol) at 0°C under an Ar atmosphere. After being stirred at the same temperature for 30 min, the reaction mixture was concentrated. The residue was dissolved in MeOH (2.0 mL). After being stirred under reflux for 10 min, the reaction mixture was concentrated. The residue was dissolved in CHCl 3 , and was washed with sat. NaHCO 3 , brine, and dried over MgSO 4 . After concentration, the crude product was used for the next step without further purification.
4-(4-{6-[(4-Methoxybenzyl
4-[4-(tert-
To a solution of 4-(tert-butyldiphenylsilyloxy)methyl-4 0 -(hydroxymethyl)benzophenone 21 7 (240.3 mg, 0.50 mmol) in CH 2 Cl 2 (15.0 mL) were added p-nitrophenyl chloroformate (151.2 mg, 0.75 mmol) and pyridine (161.4 lL, 2.00 mmol). After being stirred under reflux for 1 h, the reaction mixture was washed with brine, and dried over MgSO 4 . After concentration, the solution of the resulting residue in DMF (7.5 mL) was added to a mixture of 15 (ca. 0.20 mmol) and Et 3 N (216.8 lL) in DMF (5.0 mL). After being stirred at rt overnight, the mixture was concentrated. The residue was purified by flash column chromatography over silica gel with CHCl 3 -MeOH (1:0 to 95:5) to give the title compound 23 as colorless amorphous (471.5 mg, quant.): IR (neat) cm To a solution of 20 (ca. 0.027 mmol) in DMF (0.4 mL) were added Et 3 N (11.7 lL, 0.081 mmol) and the solution of 25 (23.3 mg, 0.027 mmol) in DMF (0.4 mL) at rt. After being stirred at the same temperature for 1 h, the reaction mixture was concentrated. The residue was subjected to preparative TLC over silica gel with CHCl 3 -MeOH (9:1) to give crude imine 26. By a procedure identical with that described for synthesis of 6 from 17, the crude 26 was converted into 7 as a colorless amorphous (10.4 mg, 36 %): IR (neat) cm To a solution of 28 (200.0 mg, 0.28 mmol) in THF (2.8 mL) was added TBAF in THF (0.55 mmol). After being stirred at rt for 2 h, the reaction mixture was quenched with sat. NH 4 Cl. The whole was extracted with EtOAc, and washed with brine, and dried over MgSO 4 . The filtrate was concentrated. To the solution of the resulting residue in THF (2.8 mL) was added NaH (22.8 mg, 0.55 mmol, 60 % oil suspension) at 0°C. After being stirred at the same temperature for 30 min, propargyl bromide (31.5 lL, 0.42 mmol) was added dropwise. After being stirred at rt overnight, the reaction was quenched with water. The whole was extracted with EtOAc, and washed with brine, and dried over MgSO 4 . After concentration, the residue was purified by flash column chromatography over aluminum oxide with n-hexane-EtOAc EC 50 = 10^[log(A/B) 9 (50 -C)/(D -C) ? log(B)], wherein A of the two points on the graph which bracket 50 % inhibition, the higher concentration of the test compound, B of the two points on the graph which bracket 50 % inhibition, the lower concentration of the test compound, C inhibitory activity (%) at the concentration B, D inhibitory activity (%) at the concentration A.
